No profile data available.
Vicapsys Life Sciences, Inc. (VICP) is a healthcare company in the blood sugar management drugs industry, based in Guaynabo, United States.
It reported revenue of $0 for fiscal year 2023, and net income of -$1.18 million. In Q3 2024 (the quarter ended September 30, 2024) revenue was $0. Its market capitalization was $17.80 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2023; market data as of October 8, 2026.
Vicapsys Life Sciences, Inc. operates as a specialty pharmaceutical wholesale distributor. The company supports pharmacies with pharmaceutical and medical equipment, products and vials. It serves all states in the United States. The company is based in Guaynabo, Puerto Rico.
Vicapsys Life Sciences reported $0 in revenue for fiscal year 2023. In Q3 2024 revenue was $0.
$17.80 million as of October 8, 2026.
Listed companies of a similar size in the same industry (blood sugar management drugs) include Novo Nordisk A/S (NVO), Oramed Pharmaceuticals Inc. (ORMP), Biomea Fusion, Inc. (BMEA).